Breast implants – patient perception of risk research

AI Summary

In July 2022, the UK Medicines and Healthcare products Regulatory Agency (MHRA) published a report produced by the research organization Revealing Reality concerning patient perceptions of breast implant risks. The study specifically investigated awareness of Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL) among cosmetic, revision, and reconstructive surgery patients. The findings revealed that patients often prioritize surgical recovery over long-term safety risks and frequently rely on social media for information. Crucially, many patients could not recall specific risk details, suggesting that current communication methods are insufficient. Under the upcoming regulatory framework for medical devices, the MHRA is introducing mandatory requirements for manufacturers to provide implant cards, ensuring patients have clear records of their devices. Additionally, the MHRA has collaborated with manufacturers to update Instructions for Use and patient brochures to include explicit details regarding BIA-ALCL. Required actions include the implementation of a new Action Plan developed with the Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group. Central to this plan is the Cosmetic Breast Augmentation Risk Awareness Tool, designed to improve both verbal and written risk communication during consultations. The MHRA recommends surgeons provide this tool at the initial consultation to ensure patients are fully informed of potential complications before proceeding. The agency is also working with professional bodies like the British Association of Plastic, Reconstructive and Aesthetic Surgeons to standardize risk information and is developing further tools for reconstructive surgery patients.